CVS vs. IDXX: CVS Health vs. IDEXX Laboratories Stock Comparison

Company Profile

CVS Health (CVS) and IDEXX Laboratories (IDXX) both fall under the Health Care Equipment & Services industry group, but CVS is classified in Health Care Providers & Services while IDXX is classified in Health Care Equipment & Supplies.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

IDEXX Laboratories (IDXX) has an aggressive beta of 1.44, indicating higher sensitivity to broad-market moves, while CVS Health (CVS) is defensive at 0.60 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

IDEXX Laboratories (IDXX) at 68.93% clears its industry range for ROE, a sharper capital-efficiency signal than CVS Health (CVS) at 14.36%, which is closer to a typical peer reading.

IDEXX Laboratories (IDXX) at 25.36% retains a top-quartile share of revenue as profit, ahead of CVS Health (CVS) at 2.64%, which keeps about the industry-typical share.

IDEXX Laboratories (IDXX) at 33.14% operates in the top operating margin quartile, ahead of CVS Health (CVS) at 2.72%, which runs around its industry’s norm.

Profitability Metrics

Growth

Both CVS Health (CVS) at 7.85% and IDEXX Laboratories (IDXX) at 10.42% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

IDEXX Laboratories (IDXX) at 22.59% is around its peer norm for EPS growth, while CVS Health (CVS) at -62.02% drops into the bottom quartile, signaling weaker earnings momentum.

Growth Metrics

Financial Strength

Both CVS Health (CVS) at 0.85 and IDEXX Laboratories (IDXX) at 1.19 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

IDEXX Laboratories (IDXX) at 0.52 carries an industry-typical debt-to-equity mix, while CVS Health (CVS) at 0.93 uses more debt funding than most peers.

Financial Strength Metrics

Dividends

IDEXX Laboratories (IDXX) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile CVS Health (CVS) reports a yield of 3.27%, ranking against industry peers normally.

IDEXX Laboratories (IDXX) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile CVS Health (CVS) reports a payout of 30.89%, ranking against industry peers normally.

Dividend Metrics

Valuation

CVS Health (CVS) at 9.74 sits in the cheaper P/E ratio quartile, while IDEXX Laboratories (IDXX) at 45.56 is closer to its industry’s usual earnings multiple — a discount for CVS, though growth and earnings durability still matter.

CVS Health (CVS) at 0.26 sits in the cheaper P/S ratio quartile while IDEXX Laboratories (IDXX) at 11.42 prices above its industry range — a wide gap in sales valuation between them.

CVS Health (CVS) at 1.33 sits in the lower P/B ratio quartile relative to book while IDEXX Laboratories (IDXX) at 28.50 prices above its industry range — a wide valuation gap against assets.

Valuation Metrics